Smith & Nephew (SNN) Cash from Discontinued Operations (2009 - 2024)
Smith & Nephew (SNN) reported Cash from Discontinued Operations of 238000000.0 for Q4 2024, up 110.62% on a YoY basis from 113000000.0 in Q1 2024, and up 110.62% quarter-over-quarter from 113000000.0 in Q4 2023.
Smith & Nephew (SNN) Cash from Discontinued Operations (2009 - 2024) Analysis & Trends
Smith & Nephew has reported Cash from Discontinued Operations for 16 years, with the latest figure at 238000000.0 in Q4 2024.
- For the quarter ending Q4 2024, Cash from Discontinued Operations rose 110.62% year-over-year to 238000000.0; the trailing twelve-month figure through Dec 2024 stood at 921000000.0 (up 21.83% YoY), and the FY2025 full-year result was 1285000000.0, up 30.19% from the prior year.
- Cash from Discontinued Operations for Q4 2024 stood at 238000000.0, up from 113000000.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 363000000.0 in Q4 2021, with the low at 73000000.0 in Q4 2020.
- Historically, Cash from Discontinued Operations has averaged 198800000.0 across 5 years, with a median of 207000000.0 in 2022.
- Annual changes were most pronounced in 2020 — Cash from Discontinued Operations tumbled 83.81% — and 2021, when it soared 397.26%.
- Smith & Nephew's Cash from Discontinued Operations stood at 73000000.0 in 2020, then soared by 397.26% to 363000000.0 in 2021, then slumped by 42.98% to 207000000.0 in 2022, then sank by 45.41% to 113000000.0 in 2023, then surged by 110.62% to 238000000.0 in 2024.
- The last three Cash from Discontinued Operations figures came in at 238000000.0 (Q4 2024), 113000000.0 (Q4 2023), and 207000000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Smith & Nephew | 5.27 Bn | 4.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 238.00 Mn |
| Dec 31, 2024 | 238.00 Mn |
| Dec 31, 2023 | 113.00 Mn |
| Dec 31, 2023 | 113.00 Mn |
| Dec 31, 2022 | 207.00 Mn |
| Dec 31, 2022 | 207.00 Mn |
| Dec 31, 2021 | 363.00 Mn |
| Dec 31, 2021 | 363.00 Mn |
| Dec 31, 2020 | 73.00 Mn |
| Dec 31, 2020 | 73.00 Mn |
| Dec 31, 2019 | 451.00 Mn |
| Dec 31, 2019 | 451.00 Mn |
| Dec 31, 2018 | 931.00 Mn |
| Dec 31, 2018 | 931.00 Mn |
| Dec 31, 2017 | 1.09 Bn |
| Dec 31, 2017 | 1.09 Bn |
| Dec 31, 2016 | 849.00 Mn |
| Dec 31, 2016 | 849.00 Mn |
| Dec 31, 2015 | 1.03 Bn |
| Dec 31, 2015 | 1.03 Bn |